Blog Archives

Predicting protein structures with a multiplayer

In a Video Game, Tackling the Complexities of Protein Folding In a match that pitted video game players against the best known computer program designed for the task, the gamers outperformed the software in figuring out how 10 proteins fold

Posted in Latests News and Alerts

Celgene to buy Abraxis for $2.9B in biotech deal

By MARLEY SEAMAN AP Health Writer NEW YORK (AP) – Biotechnology company Celgene said Wednesday it is expanding its array of cancer treatments with a deal to buy Abraxis BioScience Inc. for $2.9 billion in cash and stock. Celgene Corp.

Posted in Latests News and Alerts

New call for proposals planned to be published on 20 July 2010 – ERC Starting Grants

This grant competition is targeted at early-career research leaders, of any age, with 2-12 years of experience after their PhD. The researchers can be of any nationality as long as they are working, or moving to work, in Europe. The

Posted in Latests News and Alerts

Office of Science Announces the Early Career Research Program for FY 2011

Source: http://www.science.doe.gov/News_Information/News_Room/2010/July%201_EarlyCareer.html WASHINGTON, DC – The U.S. Department of Energy (DOE) announced today it is accepting proposals for the second year of the DOE Office of Science Early Career Research Program to support the research of outstanding scientists early in

Posted in Latests News and Alerts

Arena Pharma, Eisai to Sell Obesity Drug

source: http://online.wsj.com/article/SB10001424052748703571704575340880052218588.html NEW YORK—Arena Pharmaceuticals Inc. signed a deal for Japanese drug maker Eisai Co. to sell experimental weight-loss drug lorcaserin in the U.S., if it is approved by the Food and Drug Administration. The deal, the value of which

Posted in Latests News and Alerts

SD News: Sanofi-aventis To Acquire TargeGen, Inc.

Source: http://www.targegen.com/news063010.htm San Diego, CA – June 30, 2010- TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis (EURONEXT: SAN; NYSE:

Posted in Events News, Latests News and Alerts, Members Only, Other Events, Press Releases

One in four firms not complying with chemical legislation

Inspection data suggests that a quarter of chemical companies have not been complying with European chemicals legislation.

Posted in Doing Business with France, Latests News and Alerts, Press Releases

Bayer names ex-Novartis manager as HealthCare boss

Former Novartis COO Joerg Reinhardt to head HealthCare Healthcare * Reinhardt replaces Arthur Higgins, who leaves on April 30 * Reinhardt once tipped as possible Novartis CEO successor * Bayer shares rise 0.5 percent (Writes through, adds detail) FRANKFURT, April

Posted in Latests News and Alerts

Marie Curie International Research Staff Exchange Scheme (IRSES)

The Marie Curie International Research Staff Exchange Scheme in the People program of FP7 aims at strengthening research partnership through short staff exchanges and networking between European research organizations and organizations in Third Countries (such as the United States). This

Posted in Career, Doing Business with France, Latests News and Alerts, Members Only, Press Releases

March 16th – FABS: French American Biotech Symposium

Title: March 16th – FABS: French American Biotech SymposiumLocation: The Salk Instittute for Biological StudiesDescription: The FABS (French American Biotechnology Symposium) is a scientific seminar devoted to New Therapeutic and Vaccine Approaches to Infectious Diseases. Start Time: 08:30 AM Date:

Tagged with: , , , , ,
Posted in Doing Business with France, Events News, French BioBeach Events, Latests News and Alerts, Members Only
  • Newsletter
  • Facebook
  • LinkedIn
  • Twitter
  • Picasa
  • Flickr
  • YouTube